Project: Regulation of Stress Granules in Wild-type and VCP Mutant Neurons
Institution: University of Michigan
Project: CRISPR gene therapy for C9orf72 FTD/ALS
Institution: University of California San Francisco
Project: Development of Mutant Specific ASOs for TDP-43 and KIF5A
Institution: University of Massachusetts Chan Medical School
Project: Lipid desaturase overexpression to ameliorate neurodegeneration in C9orf72 repeat mice
Institution: University College London
Project: Compensatory effects preventing SARM1-dependent neuron and axon death (Project Renewed)
Institution: The Chancellor Masters and Scholars of the University of Cambridge
Project: Investigating stress response mechanisms in human ALS-TDP neurons (Project Renewed)
Institution: University of Massachusetts Chan Medical School
Project: Microglia regulation of selective neuronal vulnerability associated with amyotrophic lateral sclerosis (ALS) (Project Renewed)
Institution: Oregon Health & Science University
Project: Cellular and animal models of SPTLC1-related juvenile ALS
Institution: Johns Hopkins University
Project: Consequences of NUP50 mutation or loss of function in amyotrophic lateral sclerosis
Institution: INSERM (Strasbourg, France)
Project: Characterizing IL-18 PathwayInhibitors as Therapeutics for ALS
Institution: Weizmann Institute of Science (Rehovot, Israel)
Project: Dissecting the Molecular Determinants of Cytoplasmic Gain of Function Pathomechanisms in TDP - 43 - linked Amyotrophic Lateral Sclerosis
Institution: King’s College, London
Project: Alternative polyadenylation is a key feature of transcriptome dysregulation in ALS.
Institution: University of California Irvine